Canada Pension Plan Investment Board’s Fulcrum Therapeutics FULC Stock Holding History

Canada Pension Plan Investment Board’s Portfolio FULC Stock Details FULC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$141K	Buy	+18,400	New	+$171K	﹤0.01%	1621

Other funds holding FULC

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

FTM

First Turn Management Del Mar, California $895M AUM 261.28% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Canada Pension Plan Investment Board's FULC Position: Q1 2026 in Review

Canada Pension Plan Investment Board opened a new position in Fulcrum Therapeutics (FULC) in Q1 2026: 18,400 shares worth $141K. The stake represents ﹤0.01% of the portfolio and ranks #1621 among its holdings.

169 funds tracked by Wall St. Rank hold FULC as of Q1 2026.

Canada Pension Plan Investment Board held 18,400 shares of Fulcrum Therapeutics worth $141K as of Q1 2026.
Fulcrum Therapeutics was a new Canada Pension Plan Investment Board position in Q1 2026.
Fulcrum Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1621 holding.
169 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.